Literature DB >> 9862996

A detailed study of the substrate specificity of a chimeric restriction enzyme.

J Smith1, J M Berg, S Chandrasegaran.   

Abstract

Recently, the crystal structure of the designed zinc finger protein, DeltaQNK, bound to a preferred DNA sequence was reported. We have converted DeltaQNK into a novel site-specific endonuclease by linking it to the Fok I cleavage domain (FN). The substrate specificity and DNA cleavage properties of the resulting chimeric restriction enzyme (DeltaQNK-FN) were investigated, and the binding affinities of DeltaQNK and DeltaQNK-FN for various DNA substrates were determined. Substrates that are bound by DeltaQNK with high affinity are the same as those that are cleaved efficiently by DeltaQNK-FN. Substrates bound by DeltaQNK with lower affinity are cleaved with very low efficiency or not at all by DeltaQNK-FN. The binding of DeltaQNK-FN to each substrate was approximately 2-fold weaker than that for DeltaQNK. Thus, the fusion of the Fok I cleavage domain to the zinc finger motif does not change the DNA sequence specificity of the zinc finger protein and does not change its binding affinity significantly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9862996      PMCID: PMC148231          DOI: 10.1093/nar/27.2.674

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

Review 1.  Chimeric restriction enzymes: what is next?

Authors:  S Chandrasegaran; J Smith
Journal:  Biol Chem       Date:  1999 Jul-Aug       Impact factor: 3.915

2.  Stimulation of homologous recombination through targeted cleavage by chimeric nucleases.

Authors:  M Bibikova; D Carroll; D J Segal; J K Trautman; J Smith; Y G Kim; S Chandrasegaran
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains.

Authors:  J Smith; M Bibikova; F G Whitby; A R Reddy; S Chandrasegaran; D Carroll
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

Review 4.  Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.

Authors:  Taco G Uil; Hidde J Haisma; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

5.  Binding of two zinc finger nuclease monomers to two specific sites is required for effective double-strand DNA cleavage.

Authors:  Mala Mani; Jeff Smith; Karthikeyan Kandavelou; Jeremy M Berg; Srinivasan Chandrasegaran
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

Review 6.  Genome editing: a robust technology for human stem cells.

Authors:  Arun Pandian Chandrasekaran; Minjung Song; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

7.  Targeted genome modification in mice using zinc-finger nucleases.

Authors:  Iara D Carbery; Diana Ji; Anne Harrington; Victoria Brown; Edward J Weinstein; Lucy Liaw; Xiaoxia Cui
Journal:  Genetics       Date:  2010-07-13       Impact factor: 4.562

Review 8.  Custom-designed zinc finger nucleases: what is next?

Authors:  J Wu; K Kandavelou; S Chandrasegaran
Journal:  Cell Mol Life Sci       Date:  2007-11       Impact factor: 9.261

9.  Generation of myostatin B knockout yellow catfish (Tachysurus fulvidraco) using transcription activator-like effector nucleases.

Authors:  Zhangji Dong; Jiachun Ge; Zhiqiang Xu; Xiaohua Dong; Shasha Cao; Jianlin Pan; Qingshun Zhao
Journal:  Zebrafish       Date:  2014-05-09       Impact factor: 1.985

10.  Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology.

Authors:  Salvatore J Orlando; Yolanda Santiago; Russell C DeKelver; Yevgeniy Freyvert; Elizabeth A Boydston; Erica A Moehle; Vivian M Choi; Sunita M Gopalan; Jacqueline F Lou; James Li; Jeffrey C Miller; Michael C Holmes; Philip D Gregory; Fyodor D Urnov; Gregory J Cost
Journal:  Nucleic Acids Res       Date:  2010-06-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.